INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 87 filers reported holding INSYS THERAPEUTICS INC NEW in Q4 2013. The put-call ratio across all filers is 0.72 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $156,000 | -78.7% | 44,700 | -44.0% | 0.00% | -66.7% |
| Q4 2016 | $734,000 | -59.8% | 79,777 | -48.5% | 0.00% | -57.1% |
| Q3 2016 | $1,825,000 | +56.4% | 154,814 | +71.7% | 0.01% | +40.0% |
| Q2 2016 | $1,167,000 | -79.9% | 90,186 | -75.1% | 0.01% | -82.1% |
| Q1 2016 | $5,794,000 | -25.5% | 362,363 | +33.3% | 0.03% | -24.3% |
| Q4 2015 | $7,780,000 | +13.3% | 271,754 | +42.2% | 0.04% | +15.6% |
| Q2 2015 | $6,864,000 | +70.7% | 191,095 | +96.9% | 0.03% | +45.5% |
| Q1 2014 | $4,021,000 | +928.4% | 97,057 | +767.8% | 0.02% | +1000.0% |
| Q3 2013 | $391,000 | – | 11,184 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 697,763 | $27,010,000 | 4.43% |
| Tamarack Capital Management, LLC | 235,000 | $9,097,000 | 2.15% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 196,117 | $7,591,000 | 0.64% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 132,862 | $6,093,000 | 0.36% |
| EMERALD ADVISERS, LLC | 118,242 | $4,577,000 | 0.25% |
| PDT Partners, LLC | 30,038 | $1,163,000 | 0.14% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 96,334 | $3,729,000 | 0.14% |
| Convergence Investment Partners, LLC | 17,450 | $675,000 | 0.11% |
| ROTHSCHILD & CO ASSET MANAGEMENT US INC. | 122,556 | $4,744,000 | 0.11% |
| Spark Investment Management LLC | 13,992 | $541,000 | 0.09% |